You are here: Home: BCU Surgeons 1 | 2008: Robert W Carlson, MD: Select Publications

Select Publications

ATAC Trialists’ Group et al. Effect of anastrozole and tamoxifen as adjuvant treatment early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 2008;9(1):45-53. Abstract

Carlson RW et al. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw 2006;4(Suppl 3):1-22. Abstract

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;365(9472):1687-717. Abstract

Perez E et al. Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer. Proc ASCO 2007;Abstract 512.

Piccart-Gebhart MJ et al; HERA Study Team. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353(16):1659-72. Abstract

Romond EH et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353(16):1673-84. Abstract

Slamon D et al. BCIRG 006: 2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC arrowT) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC arrow TH) with docetaxel, carboplatin and trastuzumab (TCH) in Her2neu positive early breast cancer patients. San Antonio Breast Cancer Symposium 2006;Abstract 52.

Smith I et al; HERA study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial. Lancet 2007;369(9555):29-36. Abstract

Viani GA et al. Adjuvant trastuzumab in the treatment of HER-2-positive early breast cancer: A meta-analysis of published randomized trials. BMC Cancer 2007;7:153. Abstract

Wolff AC et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25(1):118-45. Abstract

 

 

 

 

Table of Contents Top of Page

CME Test Online

Home · Search

INTERVIEWS

Neil Love, MD
Editor

Monica Morrow, MD
- Select publications

Ian E Smith, MD
- Select publications

Robert W Carlson, MD
- Select publications

Soonmyung Paik, MD
- Select publications

Breast Cancer Update
for Surgeons:

A CME Audio Series and Activity

Faculty Disclosures

Editor's Office

BCU Media Center
Download PDF
Podcast
Listen to Audio Files
Read Previous Issues